IMPLANTABLE SENSOR METHOD AND SYSTEM
0 Assignments
0 Petitions

Accused Products

Abstract
Systems and methods for non-vascular sensor implantation and for measuring physiological parameters in areas of a body where the physiological parameters are heterogeneous. An implant unit is implanted in an area of a body and a foreign body capsule is allowed to form around the implant unit area. A sensor may be directed into a body cavity such as, for example, the peritoneal space, subcutaneous tissues, the foreign body capsule, or other area. A subcutaneous area of the body may be tunneled for sensor placement. Spatially separated sensing elements may be used for detecting individual amounts of the physiological parameter. An overall amount of the physiological parameter may be determined by calculating a statistical measurement of the individual sensed amounts in the area. Another embodiment of the invention, a multi-analyte measuring device, may include a substrate having an electrode array on one side and an integrated circuit on another side.
315 Citations
Analyte monitoring device and methods of use | ||
Patent #
US 7,885,699 B2
Filed 08/06/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
HIGHLY RELIABLE INGESTIBLE EVENT MARKERS AND METHODS FOR USING THE SAME | ||
Patent #
US 20110054265A1
Filed 04/27/2010
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 7,869,853 B1
Filed 08/06/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and method | ||
Patent #
US 7,920,907 B2
Filed 06/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Communication system with partial power source | ||
Patent #
US 7,978,064 B2
Filed 09/21/2009
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Biomedical Inc.
|
SENSING SYSTEM, DEVICE, AND METHOD FOR THERAPY MODULATION | ||
Patent #
US 20110196454A1
Filed 11/13/2009
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Biomedical Inc.
|
RESERVOIR BARRIER LAYER SYSTEMS AND METHODS | ||
Patent #
US 20110192478A1
Filed 04/19/2011
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Method and System for Incorporating Physiologic Data in a Gaming Environment | ||
Patent #
US 20110212782A1
Filed 10/14/2009
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same | ||
Patent #
US 8,055,334 B2
Filed 12/10/2009
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Biomedical Inc.
|
Ingestible therapy activator system and method | ||
Patent #
US 8,036,748 B2
Filed 11/13/2009
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Biomedical Inc.
|
Low voltage oscillator for medical devices | ||
Patent #
US 8,054,140 B2
Filed 10/17/2007
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Biomedical Inc.
|
INGESTIBLE EVENT MARKER SYSTEMS | ||
Patent #
US 20100185055A1
Filed 02/01/2008
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
IN-BODY DEVICE HAVING A MULTI-DIRECTIONAL TRANSMITTER | ||
Patent #
US 20100022836A1
Filed 03/07/2008
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
CALIBRATION TECHNIQUES FOR A CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100331655A1
Filed 09/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
ACTIVE SIGNAL PROCESSING PERSONAL HEALTH SIGNAL RECEIVERS | ||
Patent #
US 20100316158A1
Filed 11/19/2007
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100268047A1
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
RESERVOIR BARRIER LAYER SYSTEMS AND METHODS | ||
Patent #
US 20100016791A1
Filed 08/25/2009
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
COMMUNICATION SYSTEM WITH PARTIAL POWER SOURCE | ||
Patent #
US 20100081894A1
Filed 09/21/2009
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Biomedical Inc.
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100160748A1
Filed 03/04/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
CALIBRATION TECHNIQUES FOR A CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100198036A1
Filed 04/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
CALIBRATION TECHNIQUES FOR A CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100198035A1
Filed 04/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Porous membranes for use with implantable devices | ||
Patent #
US 20100256779A1
Filed 01/17/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100274111A1
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
IN-BODY DEVICE WITH VIRTUAL DIPOLE SIGNAL AMPLIFICATION | ||
Patent #
US 20090082645A1
Filed 09/25/2008
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Biomedical Inc.
|
IMPLANTABLE ANALYTE SENSOR | ||
Patent #
US 20090062633A1
Filed 11/04/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DEXCORN INC.
|
PATIENT CUSTOMIZED THERAPEUTIC REGIMENS | ||
Patent #
US 20090076338A1
Filed 05/02/2007
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
TRANSBODY COMMUNICATION SYSTEMS EMPLOYING COMMUNICATION CHANNELS | ||
Patent #
US 20090135886A1
Filed 11/26/2008
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Biomedical Inc.
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090177064A1
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090216101A1
Filed 02/13/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Pharma-Informatics System | ||
Patent #
US 20090227204A1
Filed 03/13/2009
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
RESERVOIR PLUNGER HEAD SYSTEMS AND METHODS | ||
Patent #
US 20090259198A1
Filed 04/03/2009
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
RESERVOIR BARRIER LAYER SYSTEMS AND METHODS | ||
Patent #
US 20090259183A1
Filed 01/26/2009
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
RESERVOIR PLUNGER HEAD SYSTEMS AND METHODS | ||
Patent #
US 20090326458A1
Filed 07/31/2009
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
ANALYTE MONITORING DEVICE AND METHODS OF USE | ||
Patent #
US 20080033271A1
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
SILICONE COMPOSITION FOR BIOCOMPATIBLE MEMBRANE | ||
Patent #
US 20080045824A1
Filed 06/14/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20080091096A1
Filed 11/16/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
LOW PROFILE ANTENNA FOR IN BODY DEVICE | ||
Patent #
US 20080306360A1
Filed 05/23/2008
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20070191699A1
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20070203411A1
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20070179370A1
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20070203410A1
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20070208247A1
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
ANALYTE MONITORING DEVICE AND METHODS OF USE | ||
Patent #
US 20070249920A1
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 20060189863A1
Filed 11/01/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 20040171921A1
Filed 02/27/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
RFID antenna for in-body device | ||
Patent #
US 8,115,618 B2
Filed 05/23/2008
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Biomedical Inc.
|
Body-associated receiver and method | ||
Patent #
US 8,114,021 B2
Filed 12/15/2009
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Biomedical Inc.
|
Porous membranes for use with implantable devices | ||
Patent #
US 8,118,877 B2
Filed 01/17/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Device and method for determining analyte levels | ||
Patent #
US 8,155,723 B2
Filed 01/28/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Calibration techniques for a continuous analyte sensor | ||
Patent #
US 8,160,671 B2
Filed 09/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,162,829 B2
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,175,673 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,177,716 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Reservoir barrier layer systems and methods | ||
Patent #
US 8,206,353 B2
Filed 08/25/2009
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,224,413 B2
Filed 10/10/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,558 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,557 B2
Filed 12/28/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,555 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,231,532 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,235,896 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Calibration techniques for a continuous analyte sensor | ||
Patent #
US 8,249,684 B2
Filed 09/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,255,031 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Multi-mode communication ingestible event markers and systems, and methods of using the same | ||
Patent #
US 8,258,962 B2
Filed 03/05/2009
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Biomedical Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,260,392 B2
Filed 06/09/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,265,726 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,273,022 B2
Filed 02/13/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,275,439 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,287,454 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,306,598 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,336 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,337 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,353,829 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,357,091 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,366,614 B2
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,372,005 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,380,273 B2
Filed 04/11/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,391,945 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,409,131 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Calibration techniques for a continuous analyte sensor | ||
Patent #
US 8,428,678 B2
Filed 05/16/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,465,425 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,473,021 B2
Filed 07/31/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,480,580 B2
Filed 04/19/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Device and method for determining analyte levels | ||
Patent #
US 8,527,026 B2
Filed 03/02/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Probablistic pharmacokinetic and pharmacodynamic modeling | ||
Patent #
US 8,540,664 B2
Filed 03/24/2010
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Low profile antenna for in body device | ||
Patent #
US 8,540,632 B2
Filed 05/23/2008
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Identifier circuits for generating unique identifiable indicators and techniques for producing same | ||
Patent #
US 8,540,633 B2
Filed 08/13/2009
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Multi-mode communication ingestible event markers and systems, and methods of using the same | ||
Patent #
US 8,542,123 B2
Filed 08/01/2012
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Body-associated receiver and method | ||
Patent #
US 8,545,436 B2
Filed 12/23/2011
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Highly reliable ingestible event markers and methods for using the same | ||
Patent #
US 8,545,402 B2
Filed 04/27/2010
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Implantable zero-wire communications system | ||
Patent #
US 8,547,248 B2
Filed 09/01/2006
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Apparatus and method for measuring biochemical parameters | ||
Patent #
US 8,558,563 B2
Filed 08/23/2010
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same | ||
Patent #
US 8,583,227 B2
Filed 09/23/2011
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,597,189 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Pharmaceutical dosages delivery system | ||
Patent #
US 8,597,186 B2
Filed 01/05/2010
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,612,159 B2
Filed 02/16/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,617,071 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,622,906 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,641,619 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,649,841 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,652,043 B2
Filed 07/20/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,660,627 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,666,469 B2
Filed 11/16/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,668,645 B2
Filed 01/03/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,670,815 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,672,844 B2
Filed 02/27/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Pharma-informatics system | ||
Patent #
US 8,674,825 B2
Filed 03/13/2009
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,688,188 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Reservoir barrier layer systems and methods | ||
Patent #
US 8,702,655 B2
Filed 04/19/2011
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Active signal processing personal health signal receivers | ||
Patent #
US 8,718,193 B2
Filed 11/19/2007
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Ingestible circuitry | ||
Patent #
US 8,721,540 B2
Filed 11/18/2010
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Communication system using an implantable device | ||
Patent #
US 8,730,031 B2
Filed 07/11/2011
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,348 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,346 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,738,109 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,744,545 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,774,887 B2
Filed 03/24/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Integrated ingestible event marker system with pharmaceutical product | ||
Patent #
US 8,784,308 B2
Filed 12/02/2010
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Communication system with enhanced partial power source and method of manufacturing same | ||
Patent #
US 8,802,183 B2
Filed 07/11/2011
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Multi-mode communication ingestible event markers and systems, and methods of using the same | ||
Patent #
US 8,810,409 B2
Filed 05/06/2013
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Communication system with partial power source | ||
Patent #
US 8,816,847 B2
Filed 06/03/2011
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Communication system incorporated in an ingestible product | ||
Patent #
US 8,836,513 B2
Filed 07/11/2011
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Membrane for use with implantable devices | ||
Patent #
US 8,840,552 B2
Filed 12/08/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,840,553 B2
Filed 02/26/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Pharma-informatics system | ||
Patent #
US 8,847,766 B2
Filed 04/28/2006
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Ingestible event marker systems | ||
Patent #
US 8,858,432 B2
Filed 02/01/2008
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Reservoir barrier layer systems and methods | ||
Patent #
US 8,858,501 B2
Filed 01/26/2009
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
System for supply chain management | ||
Patent #
US 8,868,453 B2
Filed 11/04/2010
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,880,137 B2
Filed 04/18/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Communication system with remote activation | ||
Patent #
US 8,912,908 B2
Filed 07/11/2011
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,915,850 B2
Filed 03/28/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,920,319 B2
Filed 12/28/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Device and method for determining analyte levels | ||
Patent #
US 8,923,947 B2
Filed 07/23/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
In-body device having a multi-directional transmitter | ||
Patent #
US 8,932,221 B2
Filed 03/07/2008
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Controlled activation ingestible identifier | ||
Patent #
US 8,945,005 B2
Filed 10/25/2007
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Patient customized therapeutic regimens | ||
Patent #
US 8,956,287 B2
Filed 05/02/2007
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
In-body power source having high surface area electrode | ||
Patent #
US 8,956,288 B2
Filed 02/14/2008
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
In-body device with virtual dipole signal amplification | ||
Patent #
US 8,961,412 B2
Filed 09/25/2008
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,974,386 B2
Filed 11/01/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,332 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,331 B2
Filed 12/29/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Data gathering system | ||
Patent #
US 9,014,779 B2
Filed 01/28/2011
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,014,773 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,042,953 B2
Filed 03/02/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Multi-mode communication ingestible event markers and systems, and methods of using the same | ||
Patent #
US 9,060,708 B2
Filed 07/25/2014
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,695 B2
Filed 04/12/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,697 B2
Filed 10/27/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,694 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,072,477 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,078,607 B2
Filed 06/17/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Active signal processing personal health signal receivers | ||
Patent #
US 9,083,589 B2
Filed 03/06/2014
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Reservoir plunger head systems and methods | ||
Patent #
US 9,089,637 B2
Filed 07/31/2009
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Ingestible device with pharmaceutical product | ||
Patent #
US 9,107,806 B2
Filed 11/18/2011
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Pharma-informatics system | ||
Patent #
US 9,119,554 B2
Filed 11/18/2010
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Probablistic pharmacokinetic and pharmacodynamic modeling | ||
Patent #
US 9,119,918 B2
Filed 05/08/2013
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Ingestible event markers comprising an ingestible component | ||
Patent #
US 9,149,423 B2
Filed 05/10/2010
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Body-associated receiver and method | ||
Patent #
US 9,149,577 B2
Filed 04/30/2013
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Communication system incorporated in an ingestible product | ||
Patent #
US 9,161,707 B2
Filed 09/12/2014
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Communication system incorporated in a container | ||
Patent #
US 9,198,608 B2
Filed 11/23/2011
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Apparatus, system, and method for managing adherence to a regimen | ||
Patent #
US 9,235,683 B2
Filed 11/09/2011
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Multi-mode communication ingestible event markers and systems, and methods of using the same | ||
Patent #
US 9,258,035 B2
Filed 04/29/2015
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device | ||
Patent #
US 9,268,909 B2
Filed 10/15/2013
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
In-body device having deployable antenna | ||
Patent #
US 9,270,025 B2
Filed 03/07/2008
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping | ||
Patent #
US 9,270,503 B2
Filed 09/19/2014
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Techniques for manufacturing ingestible event markers comprising an ingestible component | ||
Patent #
US 9,271,897 B2
Filed 07/22/2013
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Reservoir plunger head systems and methods | ||
Patent #
US 9,295,776 B2
Filed 04/03/2009
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Highly reliable ingestible event markers and methods for using the same | ||
Patent #
US 9,320,455 B2
Filed 01/31/2013
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,716 B2
Filed 12/05/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,714 B2
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Ingestible circuitry | ||
Patent #
US 9,415,010 B2
Filed 01/23/2013
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
In-body device with virtual dipole signal amplification | ||
Patent #
US 9,433,371 B2
Filed 01/22/2014
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Re-wearable wireless device | ||
Patent #
US 9,439,566 B2
Filed 03/15/2013
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Communication system with remote activation | ||
Patent #
US 9,439,582 B2
Filed 11/24/2014
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Active signal processing personal health signal receivers | ||
Patent #
US 9,444,503 B2
Filed 06/10/2015
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Wearable personal body associated device with various physical configurations | ||
Patent #
US 9,439,599 B2
Filed 03/08/2012
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,498,159 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Membrane for use with implantable devices | ||
Patent #
US 9,532,741 B2
Filed 07/25/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance | ||
Patent #
US 9,577,864 B2
Filed 10/03/2013
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Communication system using an implantable device | ||
Patent #
US 9,597,010 B2
Filed 04/23/2014
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Miniature ingestible device | ||
Patent #
US 9,597,487 B2
Filed 04/07/2011
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
State characterization based on multi-variate data fusion techniques | ||
Patent #
US 9,603,550 B2
Filed 03/15/2013
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,610,034 B2
Filed 11/09/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Communication system with partial power source | ||
Patent #
US 9,649,066 B2
Filed 09/25/2015
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Personal authentication apparatus system and method | ||
Patent #
US 9,659,423 B2
Filed 03/15/2013
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Pharma-informatics system | ||
Patent #
US 9,681,842 B2
Filed 01/13/2015
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Masticable ingestible product and communication system therefor | ||
Patent #
US 9,756,874 B2
Filed 01/21/2015
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping | ||
Patent #
US 9,787,511 B2
Filed 01/06/2016
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Container with electronically controlled interlock | ||
Patent #
US 9,796,576 B2
Filed 08/26/2014
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Ingestion-related biofeedback and personalized medical therapy method and system | ||
Patent #
US 9,883,819 B2
Filed 01/06/2010
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Device and method for determining analyte levels | ||
Patent #
US 9,931,067 B2
Filed 09/13/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System for supply chain management | ||
Patent #
US 9,941,931 B2
Filed 09/19/2014
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Communication system with enhanced partial power source and method of manufacturing same | ||
Patent #
US 9,962,107 B2
Filed 06/18/2014
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Membrane for use with implantable devices | ||
Patent #
US 10,039,480 B2
Filed 02/11/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Social media networking based on physiologic information | ||
Patent #
US 10,084,880 B2
Filed 11/04/2014
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping | ||
Patent #
US 10,097,388 B2
Filed 08/16/2017
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Metal detector apparatus, system, and method | ||
Patent #
US 10,175,376 B2
Filed 03/14/2014
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Electromagnetic sensing and detection of ingestible event markers | ||
Patent #
US 10,187,121 B2
Filed 07/24/2017
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,201,301 B2
Filed 04/18/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Miniature ingestible device | ||
Patent #
US 10,207,093 B2
Filed 02/09/2017
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Mobile device and system for detection and communication of information received from an ingestible device | ||
Patent #
US 10,223,905 B2
Filed 06/02/2017
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,231,654 B2
Filed 06/23/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Controlled activation ingestible identifier | ||
Patent #
US 10,238,604 B2
Filed 12/15/2014
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
System for supply chain management | ||
Patent #
US 10,305,544 B2
Filed 04/20/2017
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Data gathering system | ||
Patent #
US 10,376,218 B2
Filed 03/11/2015
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Masticable ingestible product and communication system therefor | ||
Patent #
US 10,398,161 B2
Filed 08/16/2017
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Container with electronically controlled interlock | ||
Patent #
US 10,421,658 B2
Filed 09/22/2017
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Ingestible event marker systems | ||
Patent #
US 10,441,194 B2
Filed 07/25/2014
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,478,108 B2
Filed 02/05/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping | ||
Patent #
US 10,498,572 B2
Filed 09/05/2018
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Low profile antenna for in body device | ||
Patent #
US 10,517,506 B2
Filed 05/06/2013
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Communication system with enhanced partial power source and method of manufacturing same | ||
Patent #
US 10,517,507 B2
Filed 06/18/2014
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Tracking and delivery confirmation of pharmaceutical products | ||
Patent #
US 10,529,044 B2
Filed 05/19/2011
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Communication system with partial power source | ||
Patent #
US 10,542,909 B2
Filed 03/30/2017
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Highly reliable ingestible event markers and methods for using the same | ||
Patent #
US 10,588,544 B2
Filed 02/23/2016
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Pharma-informatics system | ||
Patent #
US 10,610,128 B2
Filed 10/20/2017
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
State characterization based on multi-variate data fusion techniques | ||
Patent #
US 10,682,071 B2
Filed 03/24/2017
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Electromagnetic sensing and detection of ingestible event markers | ||
Patent #
US 10,797,758 B2
Filed 01/10/2019
|
Current Assignee
Proteus Digital Health Inc.
|
Original Assignee
Proteus Digital Health Inc.
|
Potentiometric sensors for analytic determination | ||
Patent #
US 6,251,260 B1
Filed 08/24/1998
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Wrist-worn ECG monitor with battery end of life prediction | ||
Patent #
US 5,317,269 A
Filed 01/08/1993
|
Current Assignee
Card Guard Technologies Inc.
|
Original Assignee
Instromedix Inc.
|
Systems and methods for imbedded intramuscular implants | ||
Patent #
US 6,692,520 B1
Filed 12/15/1998
|
Current Assignee
C.R. Bard Inc.
|
Original Assignee
C.R. Bard Inc.
|
Endoluminal device with indicator member for remote detection of endoleaks and/or changes in device morphology | ||
Patent #
US 6,702,847 B2
Filed 06/29/2001
|
Current Assignee
Lifeshield Sciences LLC
|
Original Assignee
Scimed Life Systems Incorporated
|
Electronic lead for a medical implant device, method of making same, and method and apparatus for inserting same | ||
Patent #
US 20030050680A1
Filed 12/27/2001
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Shaped woven tubular soft-tissue prostheses and method of manufacturing the same | ||
Patent #
US 20030078650A1
Filed 12/12/2002
|
Current Assignee
Lifeshield Sciences LLC
|
Original Assignee
Meadox Medicals Inc.
|
Method and system for non-vascular sensor implantation | ||
Patent #
US 20030078560A1
Filed 12/27/2001
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Systems and methods for remote monitoring and modulation of medical devices | ||
Patent #
US 6,558,321 B1
Filed 08/11/2000
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Reusable analyte sensor site and method of using the same | ||
Patent #
US 20020055673A1
Filed 12/21/2001
|
Current Assignee
Minimed Inc.
|
Original Assignee
Minimed Inc.
|
Glucose monitor calibration methods | ||
Patent #
US 6,424,847 B1
Filed 02/23/2000
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Implantable sensor | ||
Patent #
US 6,442,413 B1
Filed 05/15/2000
|
Current Assignee
James H. Silver
|
Original Assignee
James H. Silver
|
Sensor system | ||
Patent #
US 20020120186A1
Filed 01/08/2002
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
System and method for directing and monitoring radiation | ||
Patent #
US 6,431,175 B1
Filed 05/06/1999
|
Current Assignee
REMON BIOMEDICAL TECHNOLOGIES LTD.
|
Original Assignee
Remon Medical Technologies Ltd.
|
Analyte monitoring device and methods of use | ||
Patent #
US 6,175,752 B1
Filed 04/30/1998
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Implantable medical sensor system | ||
Patent #
US 6,201,980 B1
Filed 10/05/1998
|
Current Assignee
Lawrence Livermore National Security LLC
|
Original Assignee
Regents of the University of California
|
Multiple lens oxygen sensor for medical electrical lead | ||
Patent #
US 6,198,952 B1
Filed 10/30/1998
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Surgical kit for implantation of an injection site | ||
Patent #
US 6,206,871 B1
Filed 01/05/1999
|
Current Assignee
Claudio Zanon, Maurizio Grosso
|
Original Assignee
Claudio Zanon, Maurizio Grosso
|
Microsensor for determination of glucose and other analysis in liquids based on affinity viscosimetry | ||
Patent #
US 6,210,326 B1
Filed 07/07/1997
|
Current Assignee
Rudolf Ehwald
|
Original Assignee
Rudolf Ehwald
|
Signal processing for measurement of physiological analysis | ||
Patent #
US 6,233,471 B1
Filed 05/11/1999
|
Current Assignee
LifeScan IP Holdings LLC
|
Original Assignee
Cygnus Inc.
|
Intracranial monitoring and therapy delivery control device, system and method | ||
Patent #
US 6,248,080 B1
Filed 04/26/1999
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Biosensor | ||
Patent #
US 6,268,161 B1
Filed 05/11/1999
|
Current Assignee
M-Biotech Inc.
|
Original Assignee
M-Biotech Inc.
|
Method and kit for supplying a fluid to a subcutaneous placement site | ||
Patent #
US 6,254,586 B1
Filed 09/14/1999
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Implantable substrate sensor | ||
Patent #
US 6,259,937 B1
Filed 06/19/1998
|
Current Assignee
AFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Method of obtaining a measure of blood glucose | ||
Patent #
US 6,261,280 B1
Filed 04/17/2000
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Monitor for interventional procedures | ||
Patent #
US 6,264,611 B1
Filed 11/24/1999
|
Current Assignee
Ball Semiconductor Inc.
|
Original Assignee
Ball Semiconductor Inc.
|
Hermetic feedthrough for an implantable device | ||
Patent #
US 20010039374A1
Filed 06/14/2001
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Medical apparatus incorporating pressurized supply of storage liquid | ||
Patent #
US 6,027,479 A
Filed 02/27/1998
|
Current Assignee
Segars California Partners LP
|
Original Assignee
VIA MEDICAL CORPORATION
|
Implantable sensor and system for in vivo measurement and control of fluid constituent levels | ||
Patent #
US 6,049,727 A
Filed 04/03/1998
|
Current Assignee
Animas Corporation
|
Original Assignee
Animas Corporation
|
Glucose sensor | ||
Patent #
US D424,696 S
Filed 05/06/1999
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Glucose sensor buttons | ||
Patent #
US D426,638 S
Filed 05/06/1999
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Method and apparatus for measuring internal property distribution | ||
Patent #
US 6,075,610 A
Filed 05/09/1997
|
Current Assignee
Hamamatsu Photonics KK
|
Original Assignee
Hamamatsu Photonics KK
|
System for pancreatic stimulation and glucose measurement | ||
Patent #
US 6,093,167 A
Filed 06/16/1997
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Process for producing an electrochemical biosensor | ||
Patent #
US 6,103,033 A
Filed 03/04/1998
|
Current Assignee
Therasense Incorporated
|
Original Assignee
Therasense Incorporated
|
Light barrier for medical electrical lead oxygen sensor | ||
Patent #
US 6,125,291 A
Filed 10/30/1998
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Method of using a small volume in vitro analyte sensor | ||
Patent #
US 6,120,676 A
Filed 06/04/1999
|
Current Assignee
Therasense Incorporated
|
Original Assignee
Therasense Incorporated
|
Tissue overgrowth detector for implantable medical device | ||
Patent #
US 6,125,290 A
Filed 10/30/1998
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Implantable sensor and system for measurement and control of blood constituent levels | ||
Patent #
US 6,122,536 A
Filed 06/23/1998
|
Current Assignee
Animas Corporation
|
Original Assignee
Animas Corporation
|
Light focusing apparatus for medical electrical lead oxygen sensor | ||
Patent #
US 6,134,459 A
Filed 10/30/1998
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
System for pancreatic stimulation and glucose measurement | ||
Patent #
US 6,135,978 A
Filed 03/22/1999
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Multiple sensor assembly for medical electric lead | ||
Patent #
US 6,144,866 A
Filed 10/30/1998
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
System and method for enhancement of glucose production by stimulation of pancreatic beta cells | ||
Patent #
US 5,919,216 A
Filed 06/16/1997
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Implantable, modular tissue stimulator | ||
Patent #
US 5,941,906 A
Filed 10/15/1997
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Sensor apparatus for use in measuring a parameter of a fluid sample | ||
Patent #
US 5,932,175 A
Filed 09/25/1996
|
Current Assignee
Segars California Partners LP
|
Original Assignee
VIA MEDICAL CORPORATION
|
Subcutaneous glucose electrode | ||
Patent #
US 5,965,380 A
Filed 01/12/1999
|
Current Assignee
Therasense Incorporated
|
Original Assignee
E. Heller Company
|
Minimally invasive implantable device for monitoring physiologic events | ||
Patent #
US 5,987,352 A
Filed 03/03/1998
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Calibrated medical sensing catheter system | ||
Patent #
US 5,992,211 A
Filed 04/23/1998
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Method for increasing the service life of an implantable sensor | ||
Patent #
US 5,985,129 A
Filed 04/28/1992
|
Current Assignee
Regents of the University of California
|
Original Assignee
Regents of the University of California
|
Electrochemical sensors membrane | ||
Patent #
US 5,711,868 A
Filed 09/15/1995
|
Current Assignee
Siemens Healthcare Diagnostics Incorporated
|
Original Assignee
Chiron Corporation
|
Sensors for measuring analyte concentrations and methods of making same | ||
Patent #
US 5,707,502 A
Filed 07/12/1996
|
Current Assignee
Siemens Healthcare Diagnostics Incorporated
|
Original Assignee
Chiron Corporation
|
Implantable medical device including an arrangement for measuring a blood property having a carbon reference electrode | ||
Patent #
US 5,728,281 A
Filed 11/13/1996
|
Current Assignee
Pacesetter AB
|
Original Assignee
Pacesetter AB
|
System and method for continuous monitoring of diabetes-related blood constituents | ||
Patent #
US 5,741,211 A
Filed 10/26/1995
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Biocompatible medical lead | ||
Patent #
US 5,741,319 A
Filed 01/27/1995
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Three-layered membrane for use in an electrochemical sensor system | ||
Patent #
US 5,773,270 A
Filed 05/17/1994
|
Current Assignee
Chiron Corporation
|
Original Assignee
Chiron Corporation
|
Glucose and lactate sensors | ||
Patent #
US 5,770,028 A
Filed 12/19/1996
|
Current Assignee
Siemens Healthcare Diagnostics Incorporated
|
Original Assignee
Chiron Corporation
|
Patient monitoring system | ||
Patent #
US 5,791,344 A
Filed 01/04/1996
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Electrode assembly for assaying glucose | ||
Patent #
US 5,804,048 A
Filed 08/15/1996
|
Current Assignee
Segars California Partners LP
|
Original Assignee
VIA MEDICAL CORPORATION
|
Subcutaneous glucose electrode | ||
Patent #
US 5,593,852 A
Filed 09/01/1994
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Adam Heller, Michael V. Pishko
|
Glucose sensor assembly | ||
Patent #
US 5,660,163 A
Filed 05/18/1995
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Reagents with enhanced performance in clinical diagnostic systems | ||
Patent #
US 5,667,983 A
Filed 10/24/1994
|
Current Assignee
Siemens Healthcare Diagnostics Incorporated
|
Original Assignee
Chiron Corporation
|
Care giver data collection and reminder system | ||
Patent #
US 5,691,932 A
Filed 09/18/1996
|
Current Assignee
Reiner Associates Incorporated
|
Original Assignee
Helaine Reiner Fischer, Nobert Leo Reiner
|
Strip electrode with screen printing | ||
Patent #
US 5,682,884 A
Filed 07/27/1994
|
Current Assignee
Medisense Incorporated
|
Original Assignee
Medisense Incorporated
|
Sensor array | ||
Patent #
US 5,694,932 A
Filed 04/01/1996
|
Current Assignee
Roche Diagnostics International AG
|
Original Assignee
Disetronic Licensing Ag
|
Multilayer enzyme electrode membranes and methods of making same | ||
Patent #
US 5,696,314 A
Filed 07/12/1996
|
Current Assignee
Siemens Healthcare Diagnostics Incorporated
|
Original Assignee
Chiron Corporation
|
Glucose monitoring system | ||
Patent #
US 5,497,772 A
Filed 11/19/1993
|
Current Assignee
MANN ALFRED E. FOUNDATION FOR SCIENTIFIC RESEARCH
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Strip electrode including screen printing of a single layer | ||
Patent #
US 5,509,410 A
Filed 07/27/1994
|
Current Assignee
Medisense Incorporated
|
Original Assignee
Medisense Incorporated
|
Vascular bioartificial organ | ||
Patent #
US 5,534,025 A
Filed 06/08/1994
|
Current Assignee
The Governors of the University of Alberta
|
Original Assignee
The Governors of the University of Alberta
|
Closed loop infusion pump system with removable glucose sensor | ||
Patent #
US 5,569,186 A
Filed 04/25/1994
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Thermal transfer image-receiving sheet and process for producing the same | ||
Patent #
US 5,587,352 A
Filed 04/10/1995
|
Current Assignee
Dai Nippon Printing Company Limited
|
Original Assignee
Dai Nippon Printing Company Limited
|
Techniques to improve the performance of electrochemical sensors | ||
Patent #
US 5,411,647 A
Filed 01/25/1994
|
Current Assignee
Disetronic Licensing Ag
|
Original Assignee
Eli Lilly and Company
|
Insertion and tunneling tool for a subcutaneous wire patch electrode | ||
Patent #
US 5,300,106 A
Filed 06/07/1991
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Hydrophilic polyurethane membranes for electrochemical glucose sensors | ||
Patent #
US 5,322,063 A
Filed 10/04/1991
|
Current Assignee
Disetronic Licensing Ag
|
Original Assignee
Eli Lilly and Company
|
Implantable structure for containing substances for delivery to a body | ||
Patent #
US 5,324,518 A
Filed 03/30/1992
|
Current Assignee
BIOSYNTHESIS INC. A CORPORATION OF UT
|
Original Assignee
BIOSYNTHESIS INC.
|
Implantable medication infusion pump including self-contained acoustic fault detection apparatus | ||
Patent #
US 5,328,460 A
Filed 06/11/1993
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Pacesetter Incorporated
|
Method and apparatus for accurately displaying an ECG signal | ||
Patent #
US 5,357,969 A
Filed 03/18/1993
|
Current Assignee
Koninklijke Philips N.V.
|
Original Assignee
HP Inc.
|
Polynucleotide sequence for production of glucose oxidase in recombinant systems | ||
Patent #
US 5,266,688 A
Filed 03/06/1992
|
Current Assignee
Chiron Corporation
|
Original Assignee
Chiron Corporation
|
Production of glucose oxidase in recombinant systems | ||
Patent #
US 5,094,951 A
Filed 06/19/1989
|
Current Assignee
Chiron Corporation
|
Original Assignee
Chiron Corporation
|
Verress needle with enhanced acoustical means | ||
Patent #
US 5,139,485 A
Filed 05/03/1991
|
Current Assignee
Ethicon Incorporated
|
Original Assignee
Ethicon Incorporated
|
Biological fluid measuring device | ||
Patent #
US 4,994,167 A
Filed 07/07/1988
|
Current Assignee
DexCom Incorporated
|
Original Assignee
Markwell Medical Institute Inc.
|
Chemically sensitive transducer | ||
Patent #
US 5,039,390 A
Filed 04/11/1990
|
Current Assignee
Norbert Hampp, Christoff Brauchle
|
Original Assignee
Norbert Hampp, Christoff Brauchle
|
Two-dimensional diffusion glucose substrate sensing electrode | ||
Patent #
US 4,890,620 A
Filed 02/17/1988
|
Current Assignee
Regents of the University of California
|
Original Assignee
Regents of the University of California
|
Method of screening and selecting intraperitoneal medication infusion pump candidates | ||
Patent #
US 4,911,168 A
Filed 01/13/1989
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Pacesetter Incorporated
|
Hand-held instrument for implanting, dispensing, and inflating an inflatable membrane | ||
Patent #
US 4,802,479 A
Filed 10/31/1986
|
Current Assignee
C.R. Bard Inc.
|
Original Assignee
C.R. Bard Inc.
|
Microelectrochemical sensor and sensor array | ||
Patent #
US 4,874,500 A
Filed 07/15/1987
|
Current Assignee
MICROBIONICS INC.
|
Original Assignee
SRI International Inc.
|
Implantable gas-containing biosensor and method for measuring an analyte such as glucose | ||
Patent #
US 4,721,677 A
Filed 05/07/1987
|
Current Assignee
Childrens Hospital Medical Center
|
Original Assignee
Childrens Hospital Medical Center
|
Self-activating hydratable solid-state electrode apparatus | ||
Patent #
US 4,734,184 A
Filed 02/26/1987
|
Current Assignee
Mallinckrodt Sensor Systems Inc.
|
Original Assignee
DIAMOND SENSOR SYSTEMS INC.
|
Biological fluid measuring device | ||
Patent #
US 4,757,022 A
Filed 11/19/1987
|
Current Assignee
DexCom Incorporated
|
Original Assignee
Markwell Medical Institute Inc.
|
Robotic implantable medical device and/or component restoration system | ||
Patent #
US 4,771,772 A
Filed 10/27/1986
|
Current Assignee
Lowell D. James
|
Original Assignee
Medtronic Incorporated
|
Method and membrane applicable to implantable sensor | ||
Patent #
US 4,650,547 A
Filed 12/20/1985
|
Current Assignee
Regents of the University of California
|
Original Assignee
Regents of the University of California
|
Complete glucose monitoring system with an implantable, telemetered sensor module | ||
Patent #
US 4,703,756 A
Filed 05/06/1986
|
Current Assignee
Regents of the University of California
|
Original Assignee
Regents of the University of California
|
Device for the controlled infusion of medications | ||
Patent #
US 4,568,335 A
Filed 09/07/1982
|
Current Assignee
Markwell Medical Institute Inc.
|
Original Assignee
Markwell Medical Institute Inc.
|
Compact pulse combustion burner with enhanced heat transfer | ||
Patent #
US 4,574,745 A
Filed 07/23/1984
|
Current Assignee
ENERGY INTERNATIONAL INC.
|
Original Assignee
AMERICAN GAS ASSOCIATION
|
Liquid delivery system particularly useful as an implantable micropump for delivering insulin or other drugs | ||
Patent #
US 4,596,575 A
Filed 05/23/1984
|
Current Assignee
Bespak Corporation
|
Original Assignee
OMIKRON SCIENTIFIC LTD.
|
Robotic implantable medical device and/or component restoration system | ||
Patent #
US 4,628,928 A
Filed 12/21/1984
|
Current Assignee
Lowell D. James
|
Original Assignee
Medtronic Incorporated
|
Self-regenerating drug administration device | ||
Patent #
US 4,479,796 A
Filed 11/15/1982
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Method and membrane applicable to implantable sensor | ||
Patent #
US 4,484,987 A
Filed 05/19/1983
|
Current Assignee
Regents of the University of California
|
Original Assignee
Regents of the University of California
|
Method for monitoring blood glucose levels and elements | ||
Patent #
US 4,240,438 A
Filed 10/02/1978
|
Current Assignee
Wisconsin Alumni Research Foundation
|
Original Assignee
Wisconsin Alumni Research Foundation
|
Apparatus and method for implanted self-powered medication dispensing | ||
Patent #
US 4,003,379 A
Filed 09/24/1975
|
Current Assignee
BIOMEDICAL SYSTEMS INSTITUTE INC.
|
Original Assignee
Everett H. Ellinwood Jr
|
IMPLANTABLE INDUSION PUMP | ||
Patent #
US 3,731,681 A
Filed 01/14/1972
|
Current Assignee
Regents of The University of Minnesota
|
Original Assignee
Regents of The University of Minnesota
|
Apparatus and method for implanted self-powered medication dispensing having timing and evaluator means | ||
Patent #
US 3,923,060 A
Filed 04/23/1974
|
Current Assignee
BIOMEDICAL SYSTEMS INSTITUTE INC.
|
Original Assignee
Everett H. Ellinwood Jr
|
106 Claims
-
1-14. -14. (canceled)
-
16-24. -24. (canceled)
-
26-36. -36. (canceled)
-
38-45. -45. (canceled)
-
47-58. -58. (canceled)
-
59. A sensor system comprising:
-
a sensor for detecting a physiological parameter, the sensor configured to detect an individual sensed amount of the physiological parameter and configured to generate a signal representing the individual sensed amount; and a computing element configured to determine an amount of the physiological parameter by calculating a statistical measurement of the individual sensed amount from the signal generated from the sensor. - View Dependent Claims (15, 25, 37, 46, 60, 61, 62, 74, 82, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 105)
-
-
63-73. -73. (canceled)
-
75-81. -81. (canceled)
-
83-86. -86. (canceled)
-
99. A method for sensing a physiological parameter comprising:
-
providing a sensor for detecting a physiological parameter; detecting an individual sensed amount of the physiological parameter and generating a signal representing the individual sensed amount; and determining an amount of the physiological parameter by calculating a total statistical measurement of the individual sensed amount from the signal generated from the sensor. - View Dependent Claims (100, 101, 102, 103, 104)
-
-
106. A sensor system, the system comprising:
-
a sensor configured to detect an individual sensed amount of a physiological parameter; and a base adapted to be secured to a human body, the base configured for use with the sensor; at least one of the base and the sensor configured to receive an analyte having the physiological parameter; the base having a conduit for providing fluid communication between the base and subcutaneous tissue in a case where the base is secured to the human body.
-
1 Specification
Embodiments of the present invention relate to U.S. application Ser. No. 10/034,627, filed Dec. 27, 2001 and U.S. Provisional Application Ser. No. 60/335,627, filed Oct. 23, 2001, each entitled “Method and System for Non-Vascular Sensor Implantation,” each of which is incorporated by reference herein, and from a U.S. Provisional Application, Ser. No. 60/414,290, filed Sep. 27, 2002, entitled “Implantable Sensor Method and System,” which is also incorporated by reference herein and is a basis for a claim of priority.
1. Field of the Invention
The present invention relates to the field of in vivo sensors and, in particular, to in vivo sensors that are implanted in non-vascular areas of the body. The present invention also relates to a system and method for accurately measuring a physiological parameter in areas of a body (or external to the body) where amounts of the physiological parameter are heterogeneous in nature.
2. Description of Related Art
Traditional methods of physiological parameter sensing typically rely on vascular placement of a physiological parameter sensor. Such placement permits a sensing element such as, for example, a biomolecule, to make direct contact with the blood, providing sensing capabilities of blood components. Such sensing capabilities have greatly facilitated analysis, diagnosis and treatment of many debilitating diseases and medical conditions.
However, vascular placement of a physiological parameter sensor may suffer from several disadvantages. A physiological parameter sensor is not inserted into a vein without great difficulty and painstaking effort by an attending physician. Moreover, a physiological parameter sensor is not adjusted within or extracted from a vein without similar difficulty and effort.
Furthermore, vascular placement of a physiological parameter sensor subjects the sensor to a constant fluid environment. Such an environment may have several detrimental effects on the sensor. Due to constant fluidic contact, the sensor may suffer from decreased sensitivity, stability and effective life. Should a characteristic of the sensor be diminished to an extent rendering the sensor ineffective, the sensor must be removed and replaced, introducing the difficulties for both patient and physician associated with such removal and replacement. To complicate matters, every time a physiological parameter sensor is removed and replaced, it must be disconnected and reconnected to an implant unit utilizing the sensor output.
In an effort to assuage some of the disadvantages associated with vascular implantation of physiological parameter sensors, integrated sensor/implant unit systems have been developed. Such systems may be placed in or near a body cavity and may provide non-vascular sensing of physiological parameters. However, the incision required for such sensor/implant unit systems is relatively large and the trauma in the area of implantation can be significant. Such trauma generally prevents sensing of physiological parameters. Because such trauma may not subside for several weeks or a month or even longer, pre-implantation analysis methods used by the patient must continue. Without continuation of preimplantation analysis methods, a patient may go undiagnosed and untreated for many weeks, possibly even a month or longer. Such delay in treatment and diagnosis could be harmful or even fatal for patients who need daily diagnosis and treatment.
In addition, vascular implantation of physiological parameter sensors allow the sensing elements to sense a relatively homogenous amount of oxygen or other physiological parameter as it flows past the sensing elements. In contrast, when placing the sensor in a non-vascular area of the body, the physiological parameter may have a more heterogeneous nature, i.e., the amount of the physiological parameter may vary significantly at different locations within the non-vascular area. In such a case, the sensing element may sense the physiological parameter through diffusion from, for example, fluid around the sensing element. Thus, depending on the location of the sensing element within the non-vascular area, the amount of the physiological parameter sensed by the sensing element may more or less accurately represent the “overall amount” of the physiological parameter within the non-vascular area, i.e., an amount that accurately represents, for example, an average amount or other suitable statistical measure of the physiological parameter in the particular area of the body. In addition, another problem results from the fact that the heterogeneous nature of the physiological parameter being sensed by the sensing element may induce noise in the signal obtained from the sensing element.
Embodiments of the present invention relate to systems and methods for non-vascular sensor implantation and to a system and method for accurately measuring a physiological parameter in areas of a body (or external to the body) where amounts of the physiological parameter are heterogeneous in nature.
A method for non-vascular implant of a sensor may include implanting an implant unit in an area of a body; allowing a foreign body capsule to form around the area of the implant unit; and directing the sensor into the foreign body capsule.
Implanting an implant unit may include incising an area of the body large enough for the implant unit. Allowing a foreign body capsule to form may comprise inserting materials around the implant unit to promote growth characteristics. A material may be placed around the implant unit for promoting growth characteristics. The implant unit may include electronics and/or a pump. The electronics may be sensor electronic or other electronics. The electronics may be integrated with the pump or may be mutually exclusive from the pump.
The sensor may be attached to the implant unit. The sensor may be attached to the implant unit prior to formation of the foreign body capsule or may be attached to the implant unit subsequent to formation of the foreign body capsule.
The method may further include incising an area of the body large enough for the sensor. The incised area of the body large enough for the sensor is smaller than an incised area of the body large enough for the implant unit.
A method for non-vascular implant of a sensor may also include incising an area of a body large enough for inserting an implant unit; incising an area remote from a sensor location for inserting a sensor; directing the sensor into a body cavity; connecting the sensor to the implant unit; and inserting the implant unit into the body. The method may further include fixing the sensor in place using suture. The implant unit may be inserted into a pocket formed when incising an area of the body large enough for inserting the implant unit.
Systems for non-vascular implant may include an implant unit for delivering drug to a human body and a sensor for detecting a physiological parameter. The sensor may be separate from and connectable to the implant unit and the sensor is placed in a non-vascular area of the human body.
The implant unit may include a pump and/or electronics. The drug delivered by the implant unit may be insulin. The sensor may include a biomolecule, a lead and a sensing element. The sensing element may be a biomolecule and the biomolecule may be a glucose oxidase enzyme. The physiological parameter sensed may be oxygen or glucose. The non-vascular area of the human body where the sensor is placed may be the peritoneum or subcutaneous tissue.
A plurality of spatially separated sensing elements may be used for detecting the physiological parameter. The sensing elements may be connectable to the implant unit. The sensing elements may be implanted in a non-vascular area of the body such that each of the sensing elements sense an individual amount of the physiological parameter within the area. The sensing elements may substantially simultaneously sense individual amounts of the physiological parameter or may sense the individual amounts in succession within a given time period. An overall amount of the physiological parameter in the area may then be determined by employing a combination of the individual sensed amounts in a statistical analysis, such as in an algorithm or combined calculation.
The plurality of spatially separated sensing elements may be a one, two, or three-dimensional array of spatially separated sensing elements. Two or more sensing elements may be spatially separated in a sensor lead by a pre-determined distance. The sensor lead may include a first sensing element located at a proximal end of the sensor lead and a second sensing element located at a distal end of the sensor lead. The sensing elements may be connected to the implant unit in a daisy chain fashion.
Each of the plurality of spatially separated sensing elements may generate a signal representing an individual sensed amount of the physiological parameter. The overall amount of the physiological parameter may be determined by calculating a statistical measurement of the individual sensed amounts represented by the generated signals. The statistical measurement may be, but is not limited to, a maximum amount for the individual sensed amounts, an average amount of the individual sensed amounts, a median of the individual sensed amounts, an arithmetic mean of the individual sensed amounts, a weighted arithmetic mean of the individual sensed amounts, or the like. In this manner, a more accurate overall measurement of the physiological parameter is possible. In addition, noise induced in the signals produced by the sensing elements may be reduced by averaging the amounts of each of the plurality of spatially separated sensing elements.
Embodiments of the present invention may also include a method for non-vascular implant of a sensor including incising an area of a body large enough for inserting an implant unit; creating a tunnel in subcutaneous tissue; directing the sensor through the tunnel; connecting the sensor to the implant unit; and inserting the implant unit into the body. The tunnel may be created using a blunt instrument such as, for example, a trocar, or other blunt instrument which minimizes trauma to the subcutaneous tissue.
Embodiments of the present invention may also include a structure for defining an in vivo implant site, the structure including a cylinder having a hollow area in an interior portion thereof, wherein a portion of the cylinder is covered with a coating. The coating may be silicone rubber and the cylinder may be a right circular cylinder. The hollow area may be sufficiently large to accept a sensor. In addition, the cylinder may have at least one hole in an outer surface thereof.
Embodiments of the present invention may also include a multi-analyte measuring device having a substrate, an electrode array on a first side of the substrate, and an integrated circuit on a second side of the substrate. The electrode array and the integrated circuit may be electrically connected. The integrated circuit processes signals or monitors signals. The electrode array may include an agent, such as, for example, an enzyme. The substrate may include channels. The multi-analyte measuring device may also include a connector for providing access to the integrated circuit. The connector may connect to a display device or a monitoring device. The multi-analyte measuring device may also include a power supply, such as, for example, a battery or a capacitor.
These and other objects, features, and advantages of embodiments of the invention will be apparent to those skilled in the art from the following detailed description of embodiments of the invention when read with the drawings and appended claims.
In the following description of preferred embodiments, reference is made to the accompanying drawings which form a part hereof, and in which are shown by way of illustration specific embodiments in which the invention may be practiced. It is to be understood that other embodiments may be utilized and structural changes may be made without departing from the scope of the preferred embodiments of the present invention.
The implant unit 10 may contain electronics for data acquisition, data storage, data processing or other functions as may be required for physiological parameter sensing. In addition, the implant unit 10 may also contain, for example, a drug delivery system including a drug reservoir and a pumping mechanism to move a drug from the reservoir to a patient through, for example, a delivery catheter. The sensor 12 may sense a variety of physiological parameters. For example, the sensor 12 may sense glucose and oxygen and may be used in connection with the implant unit 10 to pump insulin for diabetics.
As can be seen in
As shown in
Also, the implant unit 10 may include its own lead that connects to the sensor lead 20. Thus, rather than connecting the sensor lead 20 to the receptacle 16, the sensor lead 20 may connect to an implant unit lead.
Once the implant unit 10 has been inserted into the subcutaneous tissue pocket and the pocket has been closed, the implant unit 10 may be left in the body for a period of time long enough that a foreign body capsule forms around the implant unit 10. The implant unit 10 may need to be left undisturbed in its position in the body for up to several weeks, a month, or longer in order to allow the foreign body capsule to form. The foreign body capsule is made up of scar tissue, primarily collagen and fibrin.
During the period when the foreign body capsule is forming, a sensor 12 may or may not be attached to the implant unit 10. If a sensor 12 is not attached to the implant unit 10, it may still be possible to use the implant unit 10 in an open-loop configuration. For example, if the implant unit 10 contains telemetry circuitry, it may be possible to communicate with the implant unit 10 from a remote location. For example, if the implant unit 10 is an insulin pump, and no sensor 12 is attached to the implant unit 10 during the period in which the foreign body capsule is forming around the implant unit 10, the patient may still analyze his or her insulin levels by traditional methods, such as, for example, using a home analysis system to take a blood sample and analyze the levels of insulin in the blood. If it is determined that the patient needs a dosage of insulin, and if the insulin pump which has been placed into the patient'"'"'s body is equipped with telemetry electronics, the patient may communicate with the insulin pump telemetrically using a portable transmitting unit and command the pump to deliver a dosage of insulin. Thus, the patient may begin to immediately use the insulin pump, without having a sensor 12 attached to the pump, in an open-loop configuration. Thus, using embodiments of the present invention, there is no need to wait for the foreign body capsule to form around the implant unit 10 before making use of the implant unit 10.
An oxygen sensor may be used in the vicinity of the foreign body capsule to determine if the foreign body capsule has formed and the area has healed. Generally, no oxygen will be detected during formation of the foreign body capsule.
Once the foreign body capsule has formed around the implant unit 10, at step 34 a small incision may be made in the vicinity of the implant unit 10 pocket allowing access to the receptacle 16 of the implant unit 10. If a sensor has been previously connected to the implant unit 10, it may be disconnected at this time. After the small incision has been made and any previously connected sensors have been disconnected from the implant unit, at step 36 the sensor 12 may be directed into the foreign body capsule. The sensing element 22 may be introduced into the foreign body capsule surrounding the implant unit through the small incision made at step 34. The sensing element 22 may be placed within the foreign body capsule. The connector 18 may reside in the subcutaneous pocket created for the implant unit 10 by the body.
In addition, a silicone plug may be used to plug the receptacle so that it remains open during the period of time the foreign body capsule is forming around the implant unit. If a silicone plug has been inserted into the receptacle 16, it may also be removed at this time.
At step 38, the sensor 12 may be connected to the implant unit 10 at the receptacle 16 on the implant unit 10 designed for connecting to the sensor 12 by connecting the connector 18 to the receptacle 16. Once the sensor 12 has been connected to the implant unit 10, the small incision may be closed at step 40. At this point, the implant unit 10 and the sensor 12 may be used in a closed-loop configuration. For example, if the implant unit 10 is an insulin pump and the sensing element 22 of the sensor 12 contains a glucose oxidase enzyme for sensing glucose and oxygen in order to determine insulin levels in the patient, the glucose and oxygen levels and, consequently, the insulin levels in the patient may be determined by the sensing element 22 in the foreign body capsule. Vascular placement of the sensor 12 is not required.
After the large incision has been made for the implant unit 10 at step 50, at step 52 a small incision may be made in a muscle wall of the cavity such as, for example, the peritoneal space, for allowing implantation of the sensor 12. The small incision may be far or remote from final placement of the sensor 12. After the small incision has been made, at step 54 the sensor 12 may be directed into the cavity. The sensing element 22 may be introduced into the cavity through the small incision made at step 52. The connector 18 may reside in the subcutaneous pocket created for the implant unit 10 by the body.
At step 56, the sensor 12 may be connected to the implant unit 10 at the receptacle 16 on the implant unit 10 designed for connecting to the sensor 12 by connecting the connector 18 to the receptacle 16. Once the sensor 12 has been connected to the implant unit 10, at step 58 the implant unit 10 may be inserted into the subcutaneous tissue pocket created at step 50. After the implant unit 10 has been inserted into the subcutaneous tissue pocket, the pocket may be closed at step 60. As before, at this point the implant unit 10 and the sensor 12 may be used in a closed-loop configuration.
After the large incision has been made for the implant unit 10 at step 70, at step 72 a small tunnel may be made for the sensor at the edge of pocket created for the implant unit 10. An incision for the tunnel may be made far or remote from final placement of the sensor 12. The tunnel may be made using a blunt, minimally traumatic tissue implant. The sensor 12 may be tunneled through the subcutaneous tissue by starting at an edge of the implant unit 10 pocket and tunneling into the subcutaneous tissue parallel to the skin. It may be desirable to stay within the subcutaneous tissue while tunneling. If the blunt, minimally traumatic tissue implant device used includes an introducer, the introducer may be left in the subcutaneous tissue while the remaining portion of the blunt, minimally traumatic tissue implant device may be removed.
After the tunnel has been made, at step 74 the sensing element 22 of sensor 12 may be directed into the introducer of the blunt, minimally traumatic tissue implant device. The connector 18 may reside in the subcutaneous pocket created for the implant unit 10 by the body. If it is desired that the sensor be fixed in its location, suture tabs such as, for example, those used on pacing leads or long term catheters may be used.
At step 76, the sensor 12 may be connected to the implant unit 10 at the receptacle 16 on the implant unit 10 designed for connecting to the sensor 12 by connecting the connector 18 to the receptacle 16. Once the sensor 12 has been connected to the implant unit 10, at step 78 the implant unit 10 may be inserted into the subcutaneous tissue pocket created at step 70. After the implant unit 10 has been inserted into the subcutaneous tissue pocket, the pocket may be closed at step 80. As before, at this point the implant unit 10 and the sensor 12 may be used in a closed-loop configuration.
The blunt, minimally traumatic tissue implant device used to tunnel the sensor 12 into a subcutaneous region may be a biopsy trocar 90 shown generally in
If so desired, a variety of materials may be placed around the implant unit 10 or sensor 12 to promote different characteristics of the foreign body capsule or sensor area. For example, if it is desired to grow more blood vessels in the area of the foreign body capsule or sensor 12, the implant unit 10 or sensor 12 may be covered with GORE-TEX or PTFE. Other materials may also be used to cover the implant unit 10 or sensor 12 depending on the nature of the characteristics of the foreign body capsule or area around the sensor 12 desired. In addition, various chemicals may be pumped into the area of the foreign body capsule in order to promote different characteristics of the foreign body capsule, such as, for example, blood vessel growth.
The implant unit 10 and the sensor 12 are modular units and may connect to each other via a mechanical interface. Because of the modularity of the implant unit 10 and the sensor 12, the sensor 12 may be removed or replaced without removing the implant unit 10. Thus, due to the small size of the sensor 12, only a small incision is required and trauma to the patient is minimized. No large incision is necessary to remove the implant unit 10 unless the implant unit 10 itself needs to be removed or replaced.
Data for sensors used in glucose sensing applications may be seen in
According to another embodiment of the present invention, a physiological parameter sensing element may be placed in any medical article or device that has surfaces that contact tissue, blood, or other bodily fluids in the course of their operation, which fluids are subsequently used in patients. This may include, for example, extracorporeal devices for use in surgery such as blood oxygenators, blood pumps, tubing used to carry blood and the like which contact blood which is then returned to the patient.
The physiological parameter sensing element may be placed in the blood oxygenator 30 in order to detect oxygen or other physiological parameters in the patient'"'"'s blood. Alternatively, the physiological parameter sensing element may be placed in an input line which feeds the patient'"'"'s blood 32 to the blood oxygenator 30 or an output line that delivers the oxygenated blood 34 to the patient. In this manner, the physiological parameter sensing element may sense a physiological parameter in the blood.
Other embodiments of the present invention address the problems described above in relation to the placement of a sensor in non-vascular areas of a body. As discussed above, when the sensing element is used in a vascular area of the body, the sensing element senses an homogenous amount of oxygen or other physiological parameter as it flows past the sensing element. However, the amount of a physiological parameter in non-vascular areas of the body may be more heterogeneous. In such a case, the sensing element may sense the physiological parameter through diffusion from, for example, fluid around the sensing element.
Thus, when the sensing element is located in non-vascular areas of the body, the heterogeneous nature of a physiological parameter in that area may result in varying amounts of the physiological parameter. In other words, the amount of a physiological parameter sensed may vary depending on the location of the sensing element within that particular area of the body. As an example, when the particular area of the body is the peritoneum and the physiological parameter is oxygen, the capillaries of the peritoneum are the sources of the oxygen. The topology of capillaries within the peritoneum may vary in different areas of the peritoneum. Thus, the oxygen levels may also vary in different areas of the peritoneum.
Therefore, using only one sensing element it may be difficult to accurately determine an “overall amount” of the physiological parameter in the non-vascular areas of the body, i.e., an amount that accurately represents, for example, an average amount or other suitable statistical measure of the physiological parameter in the particular area of the body. This is because the amount of the physiological parameter may vary depending on the location of the sensing element in the particular area of the body. In addition, another problem results from the fact that the heterogeneous nature of the physiological parameter being sensed by the sensing element may induce noise in the signal obtained from the sensing element.
In order to more accurately determine the overall amount of the physiological parameter in a particular area of the body and to reduce the amount of noise in the obtained signal, according to another embodiment of the present invention shown in
The spatial separation of sensing elements 42, 44 in sensor lead 40 is employed in order to sense the physiological parameters at different locations within the environment in which the sensor lead 40 is situated. For example, the sensing elements 42, 44 may be situated within the peritoneum and the physiological parameter to be sensed may be oxygen. By employing two or more sensing elements that are separated along the sensor lead 40, each of the sensing elements may generate a signal representing an amount of oxygen at different spatial points within the peritoneum. Thus, at any one time, or in succession within a given time period, signals representing sensed amounts of oxygen may be taken from the two or more sensing elements. The individual sensed amounts of oxygen may then be used to determine an overall amount of the physiological parameter.
This may be done, as an example, through use of an algorithm or algorithms which determine the overall amount based on the individual sensed amounts at the different locations within the environment. The algorithm or algorithms, for example, may determine the overall amount of the physiological parameter by calculating a statistical measurement of the individual sensed amounts represented by the generated signals. The statistical measurement may be, but is not limited to, a maximum amount for the individual sensed amounts, an average amount of the individual sensed amounts, a median of the individual sensed amounts, an arithmetic mean of the individual sensed amounts, or a weighted arithmetic mean of the individual sensed amounts.
The algorithm may be executed, for example, by a computing element comprising software, hardware, firmware or a combination of software, hardware, and firmware. In one embodiment, the computing element for executing the algorithm or algorithms may be implemented by electronics within an implant unit associated with the sensing elements 42 and 44, such as the electronics in implant unit 10 described above. In alternative embodiments the sensing elements may be used in or with an extracorporeal device such as a blood oxygenator and the algorithm or algorithms may be executed by a computing element associated with the extracorporeal device or by a dedicated computing element associated with the sensing elements.
As discussed above, the variance of oxygen levels may induce noise in the individual sensing elements 42, 44 of the sensor lead 40. In
In
Although in
According to embodiments of the present invention, digital signal processing may also be used either alone or in combination with a multiple element spatial sensing method according to embodiments of the present invention to reduce the noise level of the signal produced by the sensing elements, producing a smoother signal. A digital signal processor (“DSP”) may use known noise reduction techniques such as filtering, as well as other signal smoothing techniques. The DSP may be located within an implant unit associated with the sensing elements 42 and 44, such as the implant unit 10. In alternative embodiments where the sensing elements are used in an extracorporeal device such as a blood oxygenator, the DSP may be associated with the extracorporeal device or may be a dedicated DSP associated with the sensing elements.
In addition, according to other embodiments of the invention, more aggressive frequency based filtering may be used either alone or in combination with the multiple element spatial sensing and/or digital signal processing to reduce the noise level. Thus, the central frequency of the noise may be determined and the filter may be used to cut off the noise at that frequency. In one embodiment, a single-pole IIR filter is used for this purpose. However, other filters may be used depending on the application.
In
In
According to other embodiments of the present invention, in vivo calibration may be used alone or in combination with the multiple element spatial sensing, digital signal processing and/or filtering to reduce the noise level.
A placement site structure 110 used to structurally engineer a sensor placement site according to an embodiment of the present invention is shown in
Embodiments of the present invention may be used in a variety of ways. For example, embodiments of the present invention may be used in connection with THERACYTE, INC. products. THERACYTE, INC., develops and manufactures biocompatible medical device implants that deliver therapies for treatment of chronic and/or deficiency diseases, such as, for example, diabetes. THERACYTE, INC., implants may include biocompatible membranes that induce the development of capillaries close to the membranes, i.e., the implant may be vascularized. Such vascularization promotes a supply of blood to nourish the tissues within the membranes. In addition, the implant may have a thin fluid layer around a sensor placed inside of the implant or infusion site. Current products available from THERACYTE, INC., include 4.5, 20 and 40 microliter size implants. However, embodiments of the present invention can be used in connection with modifications to these products, such as, for example, implants with fewer or greater layers than the implants currently available from THERACYTE, INC.
Embodiments of the present invention may also be used in connection with reusable and non-reusable implant sites or sensor sites. For example, embodiments of the present invention may be used in connection with single or one-time implantations. As another example, embodiments of the present invention may be used in connection with a reusable analyte sensor site for use with a replaceable analyte sensor for determining a level of an analyte includes a site housing. The site housing material may be formed to have an interior cavity with an opening and a conduit that is connected to the opening of the interior tissue ingrowth and vascularization, and yet be free of tissue ingress. Also, the site housing material may permit the analyte to pass through the site housing material to the interior cavity, thus permitting measurement by the replaceable analyte sensor. In addition, the conduit may have a predetermined length to inhibit trauma and encapsulation of tissue occurring at the conduit, which is associated with placing the replaceable analyte sensor in the interior cavity of the site housing, from interfering with the tissue ingrowth and vascularization surrounding the interior cavity of the site housing material. As another example, embodiments of the present invention may be used in connection with a closed vascularized site that includes a thin layer of fluid around the sensor, or a site that has a thin fluid layer on the interior of the site that is used to transmit an analyte to the sensor from the vascularized site in the body. Embodiments of the invention such as those described above are related to U.S. Pat. No. 6,368,274, Reusable Analyte Sensor Site and Method of Using The Same, which is hereby incorporated herein by reference.
A multi-analyte measuring device 120 according to an embodiment of the present invention may be seen in
The multi-analyte measuring device 120 may be self-powered. A power supply such as, for example, a battery or a capacitor, may be used to power the device when positioned in vivo for analyte sensing or measuring. The multi-analyte measuring device 120 may be located in a variety of places in vivo, including, without limitation, in a non-vascular area of the body.
The sensor module 122 may include, without limitation, an integrated circuit 126 and an electrode array 128, as shown in
The integrated circuit 126 may be designed to facilitate a variety of applications. For example, according to one embodiment of the present invention, the integrated circuit 126 may be designed such that signals of 1 pA can be detected at a signal-to-noise ration of 100:1. The integrated circuit 126 may also be provided with the capability to make potentiometer, current and coulomb measurements, and may include signal processing, analog-to-digital, and electromagnetic communication circuitry if so desired.
The integrated circuit 126, according to an embodiment of the present invention, may be designed for low current or low charge detection in order to sense low frequency electrochemical events, possibly on the order of sub-ppm quantities for electrochemically active species of for low pulse frequency or low duration sampling of solutions containing concentrated electroactive species on the order of sub-ppm.
According to another embodiment of the present invention, the electrode array 128 environment may be separated from the integrate circuit environment. The separation of the two environments may be facilitated by a three-dimensional structure having an electrical connection between the integrated circuit 126 and the electrode array 128, such as, for example, a multilayer substrate. The structure or device used to separate the two environments may be designed for complete separation or may be designed such that the two environments are permitted to periodically or permanently intermingle, depending on the application.
According to an embodiment of the present invention, the surface of the electrode array 128 may be processed in a manner that imparts specificity to detected events. The surface of the electrode array 128 may include agents to impart specificity to detected events, the agents including, but not limited to, antigens, labeled antigens, antibodies, labeled antibodies, enzymes, membranes, size exclusion membranes, molecularly imprinted membranes, chelating agents, haptens, and other biomolecules such as DNA, for example, and the like. Furthermore, the ability to control electric potential as a function of time via the interaction of the a and an agent on any specific member to the electrode array 128 provides additional capability for enhancing the sensitivity of the multi-analyte measuring device 120.
The substrate on which the electrode array 128 resides may be processed in a manner to create one or more fluidic channels, i.e., gas or liquid channel structures, for example, for the samples containing the analytes. Samples may include, but are not limited to, blood, serum, urine, breath, stool, tissue, and the like. The fluid channel structures may be integral to the substrate containing the electrode array 128 or may be a discrete entity. The properties of the fluid channel structures may depend on the amount of sample delivered to the electrode array 128.
The electrode array 128 may be processed using techniques that are common in the industry, such as, for example, photolithography, screen printing, direct writing and the like. A variety or electrode array 128 properties may be controlled during processing, such as for example, electrode size, spacing, geometry, relative positioning, and the like. Insulators may also be used during processing if desired, and may be used, for example, to tune sensor response. Reference and auxiliary electrodes may be fabricated on the substrate containing the electrode array 128.
The multi-analyte measuring device 120 may also include a connector 124 for interfacing to an electronic monitoring device or display 130 as shown in
While particular embodiments of the present invention have been shown and described, it will be obvious to those skilled in the art that the invention is not limited to the particular embodiments shown and described and that changes and modifications may be made without departing from the spirit and scope of the appended claims.